Asano Y - Search Results

1

Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.

Saigusa R, Asano Y, Nakamura K, Miura S, Ichimura Y, Takahashi T, Toyama T, Taniguchi T, Noda S, Aozasa N, Akamata K, Sumida H, Miyazaki M, Tamaki Z, Yanaba K, Kuwano Y, Sato S. Saigusa R, et al. Among authors: asano y. J Dermatol. 2015 May;42(5):524-7. doi: 10.1111/1346-8138.12827. Epub 2015 Feb 27. J Dermatol. 2015. PMID: 25720827

2

Prevalence of 52-kd and 60-kd Ro/SS-A autoantibodies in Japanese patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Kubo M, et al. Among authors: asano y. J Am Acad Dermatol. 2002 Jul;47(1):148-51. doi: 10.1067/mjd.2002.121037. J Am Acad Dermatol. 2002. PMID: 12077598

3

The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.

Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Asano Y, et al. J Invest Dermatol. 2003 Feb;120(2):204-10. doi: 10.1046/j.1523-1747.2003.12028.x. J Invest Dermatol. 2003. PMID: 12542523 Free article.

4

Serum matrix metalloproteinase-3 in systemic sclerosis.

Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Jinnin M, et al. Among authors: asano y. Arch Dermatol Res. 2004 Jun;296(1):25-9. doi: 10.1007/s00403-004-0468-1. Epub 2004 Apr 17. Arch Dermatol Res. 2004. PMID: 15095096

5

Serum levels of manganese superoxide dismutase in patients with localized scleroderma.

Jinnin M, Ihn H, Yazawa N, Asano Y, Yamane K, Tamaki K. Jinnin M, et al. Among authors: asano y. Exp Dermatol. 2004 Jun;13(6):357-60. doi: 10.1111/j.0906-6705.2004.00160.x. Exp Dermatol. 2004. PMID: 15186321

6

Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts.

Jinnin M, Ihn H, Mimura Y, Asano Y, Yamane K, Tamaki K. Jinnin M, et al. Among authors: asano y. J Invest Dermatol. 2005 Feb;124(2):324-30. doi: 10.1111/j.0022-202X.2004.23601.x. J Invest Dermatol. 2005. PMID: 15675950 Free article.

7

Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.

Mimra Y, Ihn H, Jinnin M, Asano Y, Yamane K, Yazawa N, Tamaki K. Mimra Y, et al. Among authors: asano y. Int J Dermatol. 2005 Oct;44(10):817-20. doi: 10.1111/j.1365-4632.2005.02584.x. Int J Dermatol. 2005. PMID: 16207181

8

Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma.

Asano Y, Ihn H, Jinnin M, Mimura Y, Tamaki K. Asano Y, et al. J Invest Dermatol. 2006 Aug;126(8):1761-9. doi: 10.1038/sj.jid.5700331. Epub 2006 May 4. J Invest Dermatol. 2006. PMID: 16675963 Free article.

9

Clinical features of scleroderma patients with contracture of phalanges.

Ashida R, Ihn H, Mimura Y, Jinnin M, Asano Y, Kubo M, Tamaki K. Ashida R, et al. Among authors: asano y. Clin Rheumatol. 2007 Aug;26(8):1275-7. doi: 10.1007/s10067-006-0490-0. Epub 2006 Dec 15. Clin Rheumatol. 2007. PMID: 17171315

10

Future treatments in systemic sclerosis.

Asano Y. Asano Y. J Dermatol. 2010 Jan;37(1):54-70. doi: 10.1111/j.1346-8138.2009.00758.x. J Dermatol. 2010. PMID: 20175840 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,543 results

Search Page

Filters